BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 18, 2002
View Archived Issues
Genentech, XOMA Come Through With Strong Phase III Raptiva Data
When trying to get a drug approved, biotechnology companies must provide the FDA with data - data showing that a drug is efficacious, that it works in the appropriate patient and that it is safe, among other things. (BioWorld Today)
Read More
Trimeris, Roche Submit NDA Seeking Approval Of Fuzeon
Read More
Little-Known MSR1 Gene Links Prostate Cancer, Heart Disease, Macrophages, Atherosclerosis
Read More
IDEC Collaborates With Caprion On Proteomics-Based Discovery
Read More
Other News To Note
Read More
Onyx Regains Remainder Of Rights To ONYX-015 Program
Read More